November 12, 2019
A new type of clinical trial for dementia that aims to accelerate treatments for neurodegenerative disease by adapting one of the precision medicine approaches that have defined 21st-century cancer therapy has been developed by clinician-scientists at the UC San Francisco Memory and Aging Center (MAC). Cancer researchers, realizing that seemingly different cancer […]
